These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31162491)

  • 1. EAHP European Statements baseline survey 2015: methodology.
    Underhill J; Gibbons N
    Eur J Hosp Pharm; 2016 Mar; 23(2):65-68. PubMed ID: 31162491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EAHP European Statements Survey 2018, focusing on Section 1: Introductory Statements and Governance, Section 3: Production and Compounding, and Section 4: Clinical Pharmacy Services.
    Amann S; Underhill J; Horák P; Batista A; Miljkovic N; Gibbons N
    Eur J Hosp Pharm; 2022 Jan; 29(1):26-32. PubMed ID: 34930791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EAHP statements survey 2016: sections 1, 3 and 4 of the European Statements of Hospital Pharmacy.
    Horák P; Gibbons N; Sýkora J; Batista A; Underhill J
    Eur J Hosp Pharm; 2017 Sep; 24(5):258-265. PubMed ID: 31156955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EAHP European Statements survey 2015.
    Horák P; Gibbons N; Sýkora J; Peppard J; Miharija Gala T; Underhill J
    Eur J Hosp Pharm; 2017 May; 24(3):138-146. PubMed ID: 31156925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EAHP European Statements baseline survey 2015: results.
    Horák P; Peppard J; Sýkora J; Miharija Gala T; Underhill J; Gibbons N
    Eur J Hosp Pharm; 2016 Mar; 23(2):69-75. PubMed ID: 31157794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EAHP European Statements Survey 2017, focusing on sections 2 (Selection, Procurement and Distribution), 5 (Patient Safety and Quality Assurance) and 6 (Education and Research).
    Horák P; Underhill J; Batista A; Amann S; Gibbons N
    Eur J Hosp Pharm; 2018 Sep; 25(5):237-244. PubMed ID: 31157033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EAHP European Statements baseline survey 2015: first steps on the implementation journey.
    Peppard J; Horák P; Gibbons N; Underhill J
    Eur J Hosp Pharm; 2016 Mar; 23(2):76-79. PubMed ID: 31156821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the hospital pharmacy profession in Europe.
    Kuruc Poje D; Fitzpatrick RW; Stevens C; Machin C; Underhill J; Horák P; Batista A; Süle A; Miljković N; Plesan C; Kohl S; Marzal Lopez G
    Eur J Hosp Pharm; 2024 Apr; ():. PubMed ID: 38604616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEDICINES RECONCILIATION FOR PAEDIATRIC PATIENTS ON ADMISSION AND DISCHARGE.
    Moss M; Bilbul C; Crook J
    Arch Dis Child; 2016 Sep; 101(9):e2. PubMed ID: 27540236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AN AUDIT TO ASSESS THE TIMINGS OF TTAS AND INPATIENT ORDERS IN PAEDIATRICS; FROM WRITING, TO SCREENING, TO DISPENSING, AND TO LEAVING DISPENSARY.
    Hale A; Christiansen N; Calvert H
    Arch Dis Child; 2016 Sep; 101(9):e2. PubMed ID: 27540250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validating a hospital medicines formulary survey in the Western Pacific Region--a global hospital pharmacy initiative based on the Basel Statements.
    Penm J; Chaar B; Moles R
    Res Social Adm Pharm; 2012; 8(4):298-308. PubMed ID: 22169173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AUDIT OF OXYGEN PRESCRIBING IN A CHILDREN'S HOSPITAL.
    Wheeler L; James J; Byrne S; Forton J
    Arch Dis Child; 2016 Sep; 101(9):e2. PubMed ID: 27540216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SELF-ADMINISTRATION OF IN-PATIENT MEDICATIONS: A PILOT STUDY IN CHILDREN WITH CYSTIC FIBROSIS.
    Khan K; Harrington A; Pannu R; Bentley S; Makhecha S; Pentayya N; Pheasant C
    Arch Dis Child; 2016 Sep; 101(9):e2. PubMed ID: 27540254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacists' influences on prescribing: validating a clinical pharmacy services survey in the Western Pacific Region.
    Penm J; Chaar B; Rose G; Moles R
    Res Social Adm Pharm; 2015; 11(1):63-73. PubMed ID: 25042568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the International Pharmaceutical Federation's Basel Statements to Assess and Advance Hospital Pharmacy Practice: A Scoping Review.
    Penm J; Chaar B; Moles RJ
    Can J Hosp Pharm; 2016; 69(2):131-7. PubMed ID: 27168634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
    Colombini D; Occhipinti E
    Scand J Work Environ Health; 2018 Jul; 44(4):436-438. PubMed ID: 29961081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodology for the management of outsourced outpatient services within the NHS pharmacy service.
    Wind KI
    Eur J Hosp Pharm; 2017 May; 24(3):170-174. PubMed ID: 31156931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.